Nightstar Therapeutics plc

We are investigating the sale of Nightstar Therapeutics plc (NasdaqGS: NITE) to Biogen Switzerland Holdings GmhH. Under the terms of the proposed transaction, Nightstar stockholders will receive $25.50 in cash for each Nightstar share they own.

To receive more information regarding the investigation of Nightstar Therapeutics plc please fill out the form below.